Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

Authors: Sarah Diver, Latifa Khalfaoui, Claire Emson, Sally E. Wenzel, Andrew Menzies‐Gow, Michael E. Wechsler, James Johnston, Néstor A. Molfino, Jane R. Parnes, Ayman Megally, Gene Colice, Christopher E. Brightling - The Lancet 2021 cited by 314